Skin Ulcers Treatment With an Handicraft Topical Device

Effectiveness of Topical Negative Handicraft Device for Versus Traditional Conservative Treatment in Skin Ulcers Management in Lower Limb

The aim of this study was to evaluate the efficacy of a handicraft topical device of negative pressure versus traditional healing treatment for skin ulcers in lower limbs; in patients with diabetes mellitus, venous stasis and arterial insufficiency.

Study Overview

Status

Completed

Detailed Description

The hypothesis of this trial is that the handicraft topical device of negative pressure is even better for the treatment of skin ulcers located in the lower limbs of patients with diabetes mellitus, venous stasis and arterial insufficiency. We anticipate that in a sample of 144 patients with ulcer, will heal or at least improve with this treatment

Study Type

Interventional

Enrollment (Actual)

144

Phase

  • Phase 4

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  1. Patients with cutaneous leg ulcers due to diabetes mellitus, venous stasis and arterial insufficiency requiring healing or tissue debrided sent to managing their disease to regional general hospital No. 17, Instituto Mexicano del Seguro Social, Benito Juárez, Quintana Roo.
  2. Patients of both sexes.
  3. Patients over 18 years.
  4. Patients that have basic laboratory at admission (complete blood count with differential).
  5. Patients with comorbidities associated as Diabetes Mellitus , Hypertension, stroke, heart disease, nephropathy, venous insufficiency and arterial insufficiency, etc.

Exclusion Criteria:

  1. Hemodynamically unstable patients.
  2. Patients with septic shock from any source.
  3. Patients with deep skin ulcers with exposed some organ, data osteomyelitis, vascular-nervous exposure.
  4. Patients with secondary cutaneous ulcer enteral fistula.
  5. Patients with cutaneous ulcer or cancer tumors.
  6. Patients with cutaneous ulcer with active bleeding.
  7. Patients with cutaneous ulcer necrosis.
  8. Patients with cutaneous ulcer leishmania, insect bite.
  9. Patients with cutaneous ulcer burns.
  10. Patients who do not accept their participation in the study through informed consent.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: drenovac handcrafted
Patients treatment with the handicraft topical device negative pressure therapy Economic craft
under local anesthesia, sepsis and antisepsis, place sterile field, prepared area go out all devitalized or necrotic tissue using liquid soap surgical and irrigation back saline 0.9%. We introduce a device to distribute the negative pressure or vacuum on ulcer; conducted margins make recommendations 5-12 mm over the edge of the wound, applying negative pressure or vacuum retracted sponges, likewise for the spare fewer gauze was placed Sterile adhesive film covering the defect to seal the system cover adequately the probe output nelaton not to submit drain the system. Connect the probe to the sterile nelaton this hose and a suction system with pressure gauge, pressure -80-125 mmHg. Change it every 72 hours.
Active Comparator: Healing
Patients who were managed with traditional "conservative treatment".

Were handled as follows:

  1. Under local anesthesia, prior asepsis and antisepsis of the skin ulcer with iodinepovidone sterile fields are placed, we proceeded to debridement of all necrotic tissue or devitalized then a cure with liquid soap surgery was performed and was irrigated with 1000 cc of solution physiological 0.9%, and finally the ulcer was covered with sterile gauze.
  2. healing of skin ulcers were performed every 24 hours.
  3. the evolution of skin ulcers was evaluated every 3 days, requesting a differential valuing of clinical and biochemical form the aforementioned variables.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Presence of granulation tissue in skin ulcers.
Time Frame: 10 days
Presence of granulation tissue in 50% of the wound
10 days

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Leukocyte less than 11,000 mm3.
Time Frame: 10 days
Leukocyte less than 11,000 mm3.
10 days
Temperature
Time Frame: 10 days
less than 38 ° C temperature.
10 days
Breathing Rate
Time Frame: 10 days
less than 20 rpm breathing rate.
10 days
Heart Rate
Time Frame: 10 days
lower heart rate 90 bpm.
10 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Fany Guadalupe Pat Espadas, MCs, IMSS
  • Study Chair: Israel Augusto González González, Dr., IMSS
  • Study Director: Luis Sandoval Jurado, PhD, IMSS
  • Study Chair: Ma. Valeria Jiménez Baéz, PhD, IMSS

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

March 1, 2014

Primary Completion (Actual)

October 1, 2014

Study Completion (Actual)

January 1, 2015

Study Registration Dates

First Submitted

March 12, 2015

First Submitted That Met QC Criteria

July 29, 2015

First Posted (Estimate)

July 30, 2015

Study Record Updates

Last Update Posted (Estimate)

July 30, 2015

Last Update Submitted That Met QC Criteria

July 29, 2015

Last Verified

February 1, 2014

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Foot Ulcer

Clinical Trials on drenovac handcrafted

Subscribe